Pharmacology & Toxicology Webinars
Page 2 of 6
Considerations for Rigorous Pre-clinical Studies in Murine Muscular Dystrophy
Wednesday, August 19, 2020
Sponsors: Aurora Scientific, Inc., Myologica
Partner: Muscular Dystrophy Association
Experts present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy, including animal model selection, assays and endpoints, and how your results can inform translation to the clinic.
Characterizing Pharmaceutical Formulations Using Solid-State NMR Spectroscopy
Tuesday, July 28, 2020
Sponsor: Bruker BioSpin
An expert in pharmaceutical sciences discusses solid-state NMR spectroscopy as an advanced analytical technique to provide unique insight into the composition and properties of pharmaceutical formulations.
Obesity Webinar Series 2020
Webinar Series
June - December 2020
On-Demand
A webinar series focused on late-breaking research and discovery relating to the physiological mechanisms of obesity-related disease.
ADA 2020 CrownBio Virtual Event
Friday, June 12, 2020
Sponsor: CrownBio
Explore CrownBio’s virtual American Diabetes Association 2020 event to catch up with the latest preclinical research on diabetes, NAFLD/NASH, obesity, cardiovascular and renal diseases.
Introduction to Antibodies and their Analytical Characterization
Tuesday, June 9, 2020
Sponsor: Bruker BioSpin
An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.
Novel Method for Superior Lead Optimisation – Application to the Antiviral AZ
Tuesday, May 12, 2020
Sponsor: Bruker BioSpin
Scientists discuss the use of NMR to analyze the antiviral drug Azidothymidine AZT, a medication currently used to prevent and treat HIV/AIDS.
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerventions
Thursday, May 7, 2020
Sponsor: Scintica Instrumentation, Inc.
Experts discuss how PET/CT imaging can be used to enable image-guided neurointerventions and to study targeted delivery and clearance of therapeutic agents.
Rapid Narcotics Analysis by Orthogonal Methods: MS meets NMR
Wednesday, April 29, 2020
Experts discuss the ease of use and advantages to using a harmonized approach of Nuclear Magnetic Resonance and Mass Spectroscopy for the detection and identification of narcotics.
NMR Characterization of Polysaccharide-Based Vaccines
Tuesday, April 28, 2020
Sponsor: Bruker BioSpin
Dr. Francesco Berti describes the use of proton NMR for structural identity and conformity testing of carbohydrate-based vaccines.
Treatments of COVID-19: Old Drugs, New Tricks
Tuesday, April 21, 2020
Sponsor: Bruker BioSpin
Dr. Niamh O’Boyle, from Trinity College in Dublin, provides an overview of the SARS-CoV-2 virus and discusses the drugs that are currently in use to treat COVID-19.
Identifying Preclinical Immunotherapy Candidates Using a NHP Exploratory Toxicology Platform
Wednesday, April 8, 2020
Sponsor: CrownBio
Dr. Thomas Scullion discusses how to leverage NHP exploratory toxicology studies to guide and explore lead optimization, dosing paradigms, and future GLP studies.
Reversing Hypertriglyceridemia and Hepatic Steatosis in Dysmetabolic NHPs with a Controlled-Release Mitochondrial Protonophore (CRMP)
Thursday, February 6, 2020
Sponsor: CrownBio
Leigh Goedeke, PhD reviews spontaneous nonhuman primate (NHP) models of NAFLD and metabolic syndrome as a more clinically-relevant preclinical study platform.
Page 2 of 6